Cited by 1,841Frailty in Older AdultsNutrition and Health in AgingPharmaceutical Practices and Patient Outcomes

The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.

Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study

Open access

Hurria, Arti, Togawa, Kayo, Mohile, Supriya G., Owusu, Cynthia, Klepin, Heidi D., Gross, Cary P., Lichtman, Stuart M., Gajra, Ajeet, Bhatia, Smita, Katheria, Vani, Klapper, Shira, Hansen, Kurt, Ramani, Rupal, Lachs, Mark, Wong, F. Lennie, Tew, William P.·2011·Journal of Clinical Oncology

DOI 10.1200/jco.2011.34.7625PMC PMC3624700

Open this paper in CoChat — free account Open PDF

Abstract

Purpose: Older adults are vulnerable to chemotherapy toxicity; however, there are limited data to identify those at risk. The goals of this study are to identify risk factors for chemotherapy toxicity in older adults and develop a risk stratification schema for chemotherapy toxicity. Patients and Methods: Patients age ≥ 65 years with cancer from seven institutions completed a prechemotherapy assessment that captured sociodemographics, tumor/treatment variables, laboratory test results, and geriatric assessment variables (function, comorbidity, cognition, psychological state, social activity/support, and nutritional status). Patients were followed through the chemotherapy course to capture grade 3 (severe), grade 4 (life-threatening or disabling), and grade 5 (death) as defined by the National Cancer Institute Common Terminology Criteria for Adverse Events. Results: In total, 500 patients with a mean age of 73 years (range, 65 to 91 years) with stage I to IV lung (29%), GI (27%), gynecologic (17%), breast (11%), genitourinary (10%), or other (6%) cancer joined this prospective study. Grade 3 to 5 toxicity occurred in 53% of the patients (39% grade 3, 12% grade 4, 2% grade 5). A predictive model for grade 3 to 5 toxicity was developed that consisted of geriatric assessment variables, laboratory test values, and patient, tumor, and treatment characteristics. A scoring system in which the median risk score was 7 (range, 0 to 19) and risk stratification schema (risk score: percent incidence of grade 3 to 5 toxicity) identified older adults at low (0 to 5 points; 30%), intermediate (6 to 9 points; 52%), or high risk (10 to 19 points; 83%) of chemotherapy toxicity (P < .001). Conclusion: A risk stratification schema can establish the risk of chemotherapy toxicity in older adults. Geriatric assessment variables independently predicted the risk of toxicity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1200/jco.2011.34.7625

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Applied logistic regression
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
The Elements of Statistical Learning
Hastie, T., Tibshirani, R., & Friedman, J. (2009) · Springer Series in Statistics · doi:10.1007/978-0-387-84858-7 · Cited by 25,970
Applied Logistic Regression
Hosmer, D. W., & Lemeshow, S. (2000) · doi:10.1002/0471722146 · Cited by 20,302
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180580 · Cited by 15,291
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
Podsiadlo, D., & Richardson, S. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb01616.x · Cited by 14,418
The MOS social support survey
Sherbourne, C. D., & Stewart, A. L. (1991) · Social Science & Medicine · doi:10.1016/0277-9536(91)90150-b · Cited by 6,643
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Measuring Functioning and Well-Being: The Medical Outcomes Study Approach
Stewart, A., & Ware, J. (1992) · doi:10.7249/cb361 · Cited by 2,689

Flagged first, then by citations

Show all 43 references

1 of the 43 references couldn’t be matched to a known paper.

Sorted by citations

International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer
Wildiers, H. P. M. W., Heeren, P., Puts, M. T. E., Topinková, E., Janssen-Heijnen, M. L. G., Extermann, M., Falandry, C., Artz, A. S., Brain, E. G. C., Colloca, G. A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8347 · Cited by 1,854
Self-citation
Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology
Mohile, S. G., Dale, W., Somerfield, M. R., Schonberg, M. A., Boyd, C. M., Burhenn, P. S., Canin, B., Cohen, H. J., Holmes, H. M., Hopkins, J. O., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8687 · Cited by 1,479
Self-citation
Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score
Extermann, M., Boler, I., Reich, R. R., Lyman, G. H., Brown, R. H., DeFelice, J., Levine, R. M., Lubiner, E. T., Reyes, P., Schreiber Frederic, J., et al. (2011) · Cancer · doi:10.1002/cncr.26646 · Cited by 1,147
Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis
Levit, L. A., Balogh, E. P., Nass, S. J., & Ganz, P. A. (2014) · Cited by 956
Operationalization of Frailty Using Eight Commonly Used Scales and Comparison of Their Ability to Predict All‐Cause Mortality
Theou, O., Brothers, T. D., Mitnitski, A., & Rockwood, K. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12420 · Cited by 665
Validation of a prediction tool for chemotherapy toxicity in older adults with cancer
Hurria, A., Mohile, S., Gajra, A., Klepin, H., Muss, H., Chapman, A., Feng, T., Smith, D., Sun, C.-L., De Glas, N., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.4327 · Cited by 598
Self-citation
Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study
Mohile, S. G., Mohamed, M., Xu, H., Culakova, E., Loh, K. P., Magnuson, A. M., Flannery, M. A., Obrecht, S., Gilmore, N. J., Ramsdale, E. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01789-x · Cited by 622
Self-citation
Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study
Soubeyran, P., Bellera, C. A., Goyard, J., Heitz, D., Curé, H., Rousselot, H., Albrand, G., Servent, V., Saint‐Jean, O., Praagh, I. V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115060 · Cited by 602
Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology
Ethun, C. G., Bilen, M. A., Jani, A. B., Maithel, S. K., Ogan, K., & Master, V. A. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21406 · Cited by 590
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update
Dale, W., Klepin, H. D., Williams, G. R., Alibhai, S. M. H., Bergerot, C. D., BrintzenhofeSzoc, K., Hopkins, J. O., Jhawer, M. P., Katheria, V., Loh, K. P., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00933 · Cited by 546
Self-citation
Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer
Li, D., Sun, C., Kim, H., Soto‐Pérez‐de‐Celis, E., Chung, V. M., Koczywas, M., Fakih, M., Chao, J., Chien, L. C., Charles, K., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.4158 · Cited by 499
Self-citation
Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013
Papamichael, D., Audisio, R. A., Glimelius, B. L. G., de Gramont, A., Glynne‐Jones, R., Haller, D. G., Köhne, C. H., Rostoft, S., Lemmens, V. E. P. P., Mitry, E., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu253 · Cited by 482
Older adult participation in cancer clinical trials: A systematic review of barriers and interventions
Sedrak, M. S., Freedman, R. A., Cohen, H. J., Muss, H. B., Jatoi, A., Klepin, H. D., Wildes, T. M., Le‐Rademacher, J. G., Kimmick, G. G., Tew, W. P., et al. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21638 · Cited by 478
Self-citation
Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia
Klepin, H. D., Geiger, A. M., Tooze, J. A., Kritchevsky, S. B., Williamson, J. D., Pardee, T. S., Ellis, L. R., & Powell, B. L. (2013) · Blood · doi:10.1182/blood-2012-12-471680 · Cited by 427
Self-citation
Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement
Hurria, A., Levit, L. A., Dale, W., Mohile, S. G., Muss, H. B., Fehrenbacher, L., Magnuson, A. M., Lichtman, S. M., Bruinooge, S. S., Soto‐Pérez‐de‐Celis, E., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0319 · Cited by 420
Self-citation
Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer
Soto‐Pérez‐de‐Celis, E., Li, D., Yuan, Y., Lau, Y. M., & Hurria, A. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30348-6 · Cited by 412
Self-citation
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
Armstrong, D. K., Alvarez, R. D., Backes, F. J., Bakkum-Gamez, J. N., Barroilhet, L. M., Behbakht, K., Berchuck, A., Chen, L.-M., Chitiyo, V., Cristea, M. C., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0047 · Cited by 403
Performance of Two Geriatric Screening Tools in Older Patients With Cancer
Kenis, C., Decoster, L., Puyvelde, K. V., Grève, J. D., Conings, G., Milisen, K., Flamaing, J., Lobelle, J., & Wildiers, H. P. M. W. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.1345 · Cited by 389
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Khorana, A. A., Mangu, P. B., Berlin, J. D., Engebretson, A., Hong, T. S., Maitra, A., Mohile, S. G., Mumber, M. P., Schulick, R. D., Shapiro, M. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.5553 · Cited by 372
Self-citation
Designing Therapeutic Clinical Trials for Older and Frail Adults With Cancer: U13 Conference Recommendations
Hurria, A., Dale, W., Mooney, M., Rowland, J. H., Ballman, K. V., Cohen, H. J., Muss, H. B., Schilsky, R. L., FERRELL, B. R., Extermann, M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0418 · Cited by 364
Self-citation
Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic Review
Puts, M. T. E., Hardt, J., Monette, J., Girre, V., Springall, E., & Alibhai, S. M. H. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs285 · Cited by 335
Stimuli‐responsive nanotherapeutics for precision drug delivery and cancer therapy
Qiao, Y., Wan, J., Zhou, L., Ma, W., Yang, Y., Luo, W., Yu, Z., & Wang, H. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1527 · Cited by 332
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Sohal, D. P. S., Mangu, P. B., Khorana, A. A., Shah, M. A., Philip, P. A., O'Reilly, E. M., Uronis, H. E., Ramanathan, R. K., Crane, C. H., Engebretson, A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.1412 · Cited by 339
End Points and Trial Design in Geriatric Oncology Research: A Joint European Organisation for Research and Treatment of Cancer–Alliance for Clinical Trials in Oncology–International Society of Geriatric Oncology Position Article
Wildiers, H. P. M. W., Mauer, M. E. L., Pallis, A. G., Hurria, A., Mohile, S. G., Luciani, A., Curigliano, G., Extermann, M., Lichtman, S. M., Ballman, K. V., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.6125 · Cited by 322
Self-citation
Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)
Biganzoli, L., Battisti, N. M. L., Wildiers, H. P. M. W., McCartney, A., Colloca, G. A., Kunkler, I. H., Cardoso, M. J., Cheung, K., de Glas, N. A., Trimboli, R. M., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30741-5 · Cited by 307
Prevalence of cancer survivors in the United States
Tonorezos, E. S., Devasia, T. P., Mariotto, A. B., Mollica, M. A., Gallicchio, L. M., Green, P. A., Doose, M., Brick, R. S., Streck, B. P., Reed, C., et al. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae135 · Cited by 301
Comorbidity in older adults with cancer
Williams, G. R., MacKenzie, A. R., Magnuson, A. M., Olin, R. L., Chapman, A. E., Mohile, S. G., Allore, H. G., Somerfield, M. R., Targia, V., Extermann, M., et al. (2015) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2015.12.002 · Cited by 298
Self-citation
Geriatric Assessment-Guided Care Processes for Older Adults: A Delphi Consensus of Geriatric Oncology Experts
Mohile, S. G., Velarde, C., Hurria, A., Magnuson, A. M., Lowenstein, L. M., Pandya, C. J., O’Donovan, A., Gorawara‐Bhat, R., & Dale, W. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0137 · Cited by 281
Self-citation
Public Health Challenges and Responses to the Growing Ageing Populations
Khan, H. T. A., Addo, K. M., & Findlay, H. (2024) · Public Health Challenges · doi:10.1002/puh2.213 · Cited by 298
Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database
McCleary, N. J., Meyerhardt, J. A., Green, E., Yothers, G., de Gramont, A., Cutsem, E. V., O’Connell, M. J., Twelves, C., Saltz, L. B., Haller, D. G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.6638 · Cited by 268
The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people
Kalsi, T., Babic-Illman, G., Ross, P. J., Maisey, N. R., Hughes, S. R., Fields, P. A., Martin, F. C., Wang, Y., & Harari, D. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.120 · Cited by 265
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients
Muffly, L. S., Kocherginsky, M., Stock, W., Chu, Q., Bishop, M. R., Godley, L. A., Kline, J. P., Liu, H., Odenike, O. M., Larson, R. A., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.103655 · Cited by 255
An update on a systematic review of the use of geriatric assessment for older adults in oncology
Puts, M. T. E., dos Santos, B. S., Hardt, J., Monette, J., Girre, V., Atenafu, E. G., Springall, E., & Alibhai, S. M. H. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt386 · Cited by 254
Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy
Aaldriks, A. A., van der Geest, L. G., Giltay, E. J., le Cessie, S., Portielje, J. E. A., Tanis, B. C., Nortier, J. W. R., & Maartense, E. (2013) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2013.04.001 · Cited by 245
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology
Droz, J., Aapro, M., Balducci, L., Boyle, H. J., den Broeck, T. V., Cathcart, P. J., Dickinson, L., Efstathiou, E., Emberton, M., Fitzpatrick, J. M., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70018-x · Cited by 246
Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients
Boyle, H. J., Alibhai, S. M. H., Decoster, L., Efstathiou, E., Fizazi, K. S., Mottet, N., Oudard, S. M., Payne, H. A., Prentice, M., Puts, M. T. E., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.04.031 · Cited by 246
Cancer and Aging: Two Tightly Interconnected Biological Processes
Berben, L., Floris, G., Wildiers, H. P. M. W., & Hatse, S. (2021) · Cancers · doi:10.3390/cancers13061400 · Cited by 253
Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy
Hoppe, S., Rainfray, M., Fonck, M., Hoppenreys, L., Blanc, J., Ceccaldi, J., Mertens, C., Blanc-Bisson, C., Imbert, Y., Cany, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.7430 · Cited by 236
Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis
Liao, W., Chien, K., Lin, Y., Wu, M., Lin, J., Wang, H., & Tu, Y. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70388-7 · Cited by 229
Designing nanomedicine for immuno-oncology
Jiang, W., Roemeling, C. A. V., Chen, Y., Qie, Y., Liu, X., Chen, J., & Kim, B. Y. S. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0029 · Cited by 230
Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies
Kelly, C. M., & Shahrokni, A. (2016) · Journal of Oncology · doi:10.1155/2016/6186543 · Cited by 229
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021
Dotan, E., Walter, L. C., Browner, I. S., Clifton, K., Cohen, H. J., Extermann, M., Gross, C. P., Gupta, S. V., Hollis, G., Hubbard, J. M., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0043 · Cited by 220
Self-citation
Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients
Aparicio, T., Jouve, J., Teillet, L., Gargot, D., Subtil, F., Brun-Ly, V. L., Cretin, J., Locher, C., Bouché, O., Breysacher, G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.9894 · Cited by 216
Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial
Argiris, A. E., Ghebremichael, M. S., Gilbert, J., Lee, J., Sachidanandam, K., Kolesar, J., Burtness, B. A., & Forastiere, A. A. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.4272 · Cited by 210
Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy
Cohen, H. J., Smith, D., Sun, C., Tew, W., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Lichtman, S. M., Gajra, A., et al. (2016) · Cancer · doi:10.1002/cncr.30269 · Cited by 203
Self-citation
Association between cachexia, chemotherapy and outcomes in older cancer patients: A systematic review
Caillet, P., Liuu, É., Raynaud-Simon, A., Bonnefoy, M., Guérin, O., Berrut, G., Lesourd, B., Jeandel, C., Ferry, M., Rolland, Y., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.12.003 · Cited by 207
The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)
Lund, C. M., Vistisen, K. K., Olsen, A. P., Bardal, P., Schultz, M., Dolin, T. G., Rønholt, F., Johansen, J. S., & Nielsen, D. L. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01367-0 · Cited by 214
How Is Geriatric Assessment Used in Clinical Practice for Older Adults With Cancer? A Survey of Cancer Providers by the American Society of Clinical Oncology
Dale, W., Williams, G. R., MacKenzie, A. R., Soto‐Pérez‐de‐Celis, E., Maggiore, R. J., Merrill, J. K., Katta, S., Smith, K. T., & Klepin, H. D. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00442 · Cited by 204
Self-citation
Polypharmacy and potentially inappropriate medication use in geriatric oncology
Sharma, M., Loh, K. P., Nightingale, G., Mohile, S. G., & Holmes, H. M. (2016) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2016.07.010 · Cited by 198
Self-citation
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer
Hall, P. S., Swinson, D., Cairns, D. A., Waters, J. S., Petty, R., Allmark, C., Ruddock, S., Falk, S. J., Wadsley, J., Roy, R., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.0848 · Cited by 198
Chemotherapy for colorectal cancer in the elderly
Kim, J. H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i17.5158 · Cited by 193
Outcome of older patients with acute myeloid leukemia
Thein, M. S., Ershler, W. B., Jemal, A., Yates, J. W., & Baer, M. R. (2013) · Cancer · doi:10.1002/cncr.28129 · Cited by 192
In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles
Baksi, R., Singh, D. P., Borse, S., Rana, R., Sharma, V., & Nivsarkar, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.106 · Cited by 192
Frailty and Cancer: Current Perspectives on Assessment and Monitoring
Goede, V. (2023) · Clinical Interventions in Aging · doi:10.2147/cia.s365494 · Cited by 198
Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012
Joly, F., Giffard, B., Rigal, O., de Ruiter, M. B., Small, B. J., Dubois, M., Fel, J. L., Schagen, S. B., Ahles, T. A., Wefel, J. S., et al. (2015) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2015.06.019 · Cited by 185
Surgical Considerations in Older Adults With Cancer
Korc‐Grodzicki, B., Downey, R. J., Shahrokni, A., Kingham, T. P., Patel, S. G., & Audisio, R. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.0962 · Cited by 185
Artificial intelligence in oncology: path to implementation
Chua, I. S., Gaziel‐Yablowitz, M., Korach, Z. T., Kehl, K. L., Levitan, N. A., Arriaga, Y. E., Jackson, G. P., Bates, D. W., & Hassett, M. (2021) · Cancer Medicine · doi:10.1002/cam4.3935 · Cited by 179
Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology
Pallis, A. G., Gridelli, C., Wedding, U., Finn, C. F., Veronesi, G., Jaklitsch, M. T., Luciani, A., & O'Brien, M. E. R. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu022 · Cited by 186
Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment
Paillaud, É., Caillet, P., Laurent, M., Bastuji‐Garin, S., Liuu, É., Lagrange, J., Culine, S., & Canouï‐Poitrine, F. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s57849 · Cited by 180
Impact of Age and Comorbidity on Non–Small-Cell Lung Cancer Treatment in Older Veterans
Wang, S., Wong, M. L., Hamilton, N., Davoren, J. B., Jahan, T. M., & Walter, L. C. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5269 · Cited by 177
Frailty index developed from a cancer-specific geriatric assessment and the association with mortality among older adults with cancer
Guerard, E. J., Deal, A. M., Chang, Y., Williams, G. R., Nyrop, K. A., Pergolotti, M., Muss, H. B., Sanoff, H. K., & Lund, J. L. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0122 · Cited by 168
The effect of a geriatric evaluation on treatment decisions for older cancer patients – a systematic review
Hamaker, M. E., Schiphorst, A. H. W., Huinink, D. T. B., Schaar, C. G., & Munster, B. C. V. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.840741 · Cited by 171
Systematic review of falls in older adults with cancer
Wildes, T. M., Dua, P., Fowler, S. A., Miller, J. P., Carpenter, C. R., Avidan, M. S., & Stark, S. L. (2014) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2014.10.003 · Cited by 167
The Value of Geriatric Assessments in Predicting Treatment Tolerance and All-Cause Mortality in Older Patients With Cancer
Hamaker, M. E., Vos, A. G., Smorenburg, C. H., de Rooij, S. E., & Munster, B. C. V. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0186 · Cited by 167
What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper
Loh, K. P., Soto‐Pérez‐de‐Celis, E., Hsu, T., de Glas, N. A., Battisti, N. M. L., Baldini, C., Rodrigues, M. J., Lichtman, S. M., & Wildiers, H. P. M. W. (2018) · Journal of Oncology Practice · doi:10.1200/jop.2017.026435 · Cited by 170
Self-citation
Management of pancreatic cancer in the elderly
Higuera, O. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.764 · Cited by 164
Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane–Based Chemotherapy for Early-Stage Breast Cancer
Shachar, S. S., Deal, A. M., Weinberg, M., Williams, G. R., Nyrop, K. A., Popuri, K., Choi, S. K., & Muss, H. B. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2266 · Cited by 167
Time to Stop Saying Geriatric Assessment Is Too Time Consuming
Hamaker, M. E., Wildes, T. M., & Rostoft, S. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.8170 · Cited by 159
Anticancer effect of antimalarial artemisinin compounds
Das, A. (2015) · Annals of Medical and Health Sciences Research · doi:10.4103/2141-9248.153609 · Cited by 157
The prevalence of potentially modifiable functional deficits and the subsequent use of occupational and physical therapy by older adults with cancer
Pergolotti, M., Deal, A. M., Lavery, J. A., Reeve, B. B., & Muss, H. B. (2015) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2015.01.004 · Cited by 161
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions
Karam, A., Ledermann, J. A., Kim, J.-W., Sehouli, J., Lu, K., Gourley, C., Katsumata, N., Burger, R. A., Nam, B.-H., Bacon, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx011 · Cited by 153
Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer
Magnuson, A. M., Sedrak, M. S., Gross, C. P., Tew, W. P., Klepin, H. D., Wildes, T. M., Muss, H. B., Dotan, E., Freedman, R. A., O’Connor, T. L., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.02063 · Cited by 151
Self-citation
The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy
Hamaker, M. E., Mitrovic, M., & Stauder, R. (2014) · Annals of Hematology · doi:10.1007/s00277-013-2001-0 · Cited by 149
Treatment of Older Patients With Head and Neck Cancer: A Review
VanderWalde, N. A., Fleming, M. E., Weiss, J. M., & Chera, B. S. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0427 · Cited by 147
Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy
Popa, M. A., Wallace, K., Brunello, A., Extermann, M., & Balducci, L. (2014) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2014.04.002 · Cited by 145
The relationship between age, anxiety, and depression in older adults with cancer
Wiesel, T. W., Nelson, C. J., Tew, W. P., Hardt, M. E., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Gajra, A., Lichtman, S. M., et al. (2014) · Psycho-Oncology · doi:10.1002/pon.3638 · Cited by 151
Self-citation
Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older
Forero, A., Holkova, B., Goldschmidt, J. H., Chen, R., Olsen, G. A., Boccia, R. V., Bordoni, R. E., Friedberg, J. W., Sharman, J. P., Palanca-Wessels, M. C., et al. (2015) · Blood · doi:10.1182/blood-2015-06-644336 · Cited by 145
Physical performance measures for predicting outcome in cancer patients: a systematic review
Verweij, N. M., Schiphorst, A. H. W., Pronk, A., van den Bos, F., & Hamaker, M. E. (2016) · Acta Oncologica · doi:10.1080/0284186x.2016.1219047 · Cited by 142
Polypharmacy and Potentially Inappropriate Medication Use in Older Adults with Cancer Undergoing Chemotherapy: Effect on Chemotherapy‐Related Toxicity and Hospitalization During Treatment
Maggiore, R. J., Dale, W., Gross, C. P., Feng, T., Tew, W. P., Mohile, S. G., Owusu, C., Klepin, H. D., Lichtman, S. M., Gajra, A., et al. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12942 · Cited by 140
Self-citation
Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group
Hamaker, M. E., Seynaeve, C., Wymenga, A. N. M., van Tinteren, H., Nortier, J. W. R., Maartense, E., de Graaf, H., de Jongh, F. E., Braun, J. J., Los, M., et al. (2013) · The Breast · doi:10.1016/j.breast.2013.11.004 · Cited by 140
Solid-Organ Transplantation in Older Adults: Current Status and Future Research
Abecassis, M. M., Bridges, N. D., Clancy, C. J., Dew, M. A., Eldadah, B. A., Englesbe, M. J., Flessner, M. F., Frank, J. C., Friedewald, J. J., Gill, J. S., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04245.x · Cited by 140
Participation of the Elderly Population in Clinical Trials: Barriers and Solutions
Denson, A. C., & Mahipal, A. (2014) · Cancer Control · doi:10.1177/107327481402100305 · Cited by 142
A Practical Guide to Geriatric Syndromes in Older Adults With Cancer: A Focus on Falls, Cognition, Polypharmacy, and Depression
Magnuson, A. M., Sattar, S., Nightingale, G., Saracino, R. M., Skonecki, E., & Trevino, K. M. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_237641 · Cited by 138
Best Practices for Reducing Unplanned Acute Care for Patients With Cancer
Handley, N. R., Schuchter, L. M., & Bekelman, J. E. (2018) · Journal of Oncology Practice · doi:10.1200/jop.17.00081 · Cited by 137
Cognitive dysfunctions in elderly cancer patients: A new challenge for oncologists
Lange, M., Rigal, O., Clarisse, B., Giffard, B., Sevin, E., Barillet, M., Eustache, F., & Joly, F. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.03.003 · Cited by 139
Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) –Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline
Denduluri, N., Somerfield, M. R., Eisen, A. F., Holloway, J. N., Hurria, A., King, T. A., Lyman, G. H., Partridge, A. H., Telli, M. L., Trudeau, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.0182 · Cited by 134
Self-citation
Systemic, perioperative management of muscle-invasive bladder cancer and future horizons
Funt, S. A., & Rosenberg, J. E. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.188 · Cited by 134
Pilot Study of Comprehensive Geriatric Assessment (CGA) in Allogeneic Transplant: CGA Captures a High Prevalence of Vulnerabilities in Older Transplant Recipients
Muffly, L. S., Boulukos, M., Swanson, K., Kocherginsky, M., del Cerro, P., Schroeder, L., Pape, L., Extermann, M., van Besien, K., & Artz, A. S. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.11.006 · Cited by 130
Occupational Therapy for Adults With Cancer: Why It Matters
Pergolotti, M., Williams, G. R., Campbell, C., Munoz, L. A., & Muss, H. B. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0335 · Cited by 128
Impact of Age and Comorbidity on Treatment and Outcomes in Elderly Cancer Patients
Chen, R. C., Royce, T. J., Extermann, M., & Reeve, B. B. (2012) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2012.05.002 · Cited by 134
Improving the quality of survivorship for older adults with cancer
Mohile, S. G., Hurria, A., Cohen, H. J., Rowland, J. H., Leach, C. R., Arora, N., Canin, B. E., Muss, H. B., Magnuson, A. M., Flannery, M. A., et al. (2016) · Cancer · doi:10.1002/cncr.30053 · Cited by 127
Self-citation
Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment
Lange, M., Heutte, N., Rigal, O., Noal, S., Kurtz, J., Lévy, C., Allouache, D., Rieux, C., Fel, J. L., Clarisse, B., et al. (2016) · The Oncologist · doi:10.1634/theoncologist.2016-0014 · Cited by 125
Decision Making in Older Adults With Cancer
DuMontier, C., Loh, K. P., Soto‐Pérez‐de‐Celis, E., & Dale, W. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00165 · Cited by 125
Social support for older adults with cancer: Young International Society of Geriatric Oncology review paper
Kadambi, S. G., Soto‐Pérez‐de‐Celis, E., Garg, T. K., Loh, K. P., Krok‐Schoen, J. L., Battisti, N. M. L., Moffat, G. T., Gil, L. A., Mohile, S. G., & Hsu, T. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.09.005 · Cited by 123
Self-citation
Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer
Wildes, T. M., Ruwe, A. P., Fournier, C., Gao, F., Carson, K. R., Piccirillo, J. F., Tan, B. R., & Colditz, G. A. (2013) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2013.02.002 · Cited by 123
Beyond Performance Status
Simcock, R., & Wright, J. E. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.06.016 · Cited by 129
Geriatric Assessment and Management in Cancer
Rostoft, S., O’Donovan, A., Soubeyran, P., Alibhai, S. M. H., & Hamaker, M. E. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00089 · Cited by 120
Polypharmacy and the management of the older cancer patient
Balducci, L., Goetz-Parten, D. E., & Steinman, M. A. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt266 · Cited by 119
Geriatric assessment with management in cancer care: Current evidence and potential mechanisms for future research
Magnuson, A. M., Allore, H. G., Cohen, H. J., Mohile, S. G., Williams, G. R., Chapman, A. E., Extermann, M., Olin, R. L., Targia, V., MacKenzie, A. R., et al. (2016) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2016.02.007 · Cited by 114
Self-citation
Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross‐sectional survey (NutriAgeCancer)
Poisson, J., Martinez‐Tapia, C., Heitz, D., Geiss, R., Albrand, G., Falandry, C., Gisselbrecht, M., Couderc, A., Boulahssass, R., Liuu, É., et al. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12776 · Cited by 116

Authors: Hurria, A., Togawa, K., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Lichtman, S. M., Gajra, A., Bhatia, S., Katheria, V., Klapper, S., Hansen, K., Ramani, R., Lachs, M., Wong, F. L., & Tew, W. P.
Affiliations: City Of Hope National Medical Center (US)
Arti Hurria, Kayo Togawa, Smita Bhatia, Rupal Ramani, and F. Lennie Wong, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte; Kurt Hansen, University of California Davis School of Medicine, Sacramento, CA; Supriya G. Mohile, University of Rochester Medical Center, Rochester; Stuart M. Lichtman, Shira Klapper, and William P. Tew, Memorial Sloan-Kettering Cancer Center; Mark Lachs, Weill Cornell Medical College, New York; Ajeet Gajra, State University of New York Upstate...
ORCID: Hurria, Arti
Togawa, Kayo
Mohile, Supriya G.
Owusu, Cynthia
Klepin, Heidi D.
Gross, Cary P.
Lichtman, Stuart M.
Gajra, Ajeet
Katheria, Vani
Lachs, Mark
Wong, F. Lennie
Tew, William P.
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2011-09-01
Volume: 29
Issue: 25
Pages: 3457-3465
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.2011.34.7625
PMC: PMC3624700
OpenAlex: W2153294383
Cited by: 1,841
References: 43
Citations by year: 2026: 98 · 2025: 98 · 2024: 117 · 2023: 119 · 2022: 153 · 2021: 149 · 2020: 148 · 2019: 147 · 2018: 143 · 2017: 129 · 2016: 134 · 2015: 114 · 2014: 112 · 2013: 87 · 2012: 73
FWCI: 43.61
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Oncology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Amgen
GlaxoSmithKline
American Society of Clinical Oncology
Celgene
Genentech
National Institute on Aging (K24AG022399, 1K08 AG 24842, K08AG024842, K23AG038361, K23AG026749)
National Cancer Institute (U10CA098543)
Topics: Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords: chemotherapy toxicity, older adults, geriatric assessment, risk stratification, risk prediction model, comorbidities, functional status, nutritional status, cognitive status, laboratory parameters, geriatric oncology
MeSH terms: Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Neoplasms, Predictive Value of Tests, Prospective Studies, Comorbidity, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks